In a groundbreaking study published in The Lancet, researchers have revealed that statins, commonly prescribed cholesterol-lowering medications, do not cause most of the side effects listed on their packaging. This research comes as a relief to many patients who have been concerned about potential negative reactions to these widely-used drugs. The study analyzed extensive data from clinical trials and found that reported side effects such as muscle pain, fatigue, and liver issues are largely overestimated. This new insight encourages healthcare professionals to reassess the risk-to-benefit ratio of prescribing statins and may lead to a reduction in patient hesitancy towards using these life-saving medications. With cardiovascular diseases being one of the leading causes of mortality globally, statins play a crucial role in prevention, making this study a significant advancement in the medical field. The findings urge a renewed dialogue between patients and doctors about the actual benefits and minimal risks of statin therapy.
statnews.comNew data shows smarter solutions to change-of-mind returns as retailers crack down
August 3, 2026
In a bid to address the rising costs associated with change-of-mind returns, many retailers are implementing stricter policies. However, recent data suggests that a more